Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 4/20 | 1.00 |
| ▸ | GRIK2 | Q13002 | 4/20 | 1.00 |
| ▸ | SLC1A2 | P43004 | 7/20 | 0.96 |
| ▸ | SLC1A1 | P43005 | 6/20 | 0.96 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28902633 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL29156799 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL9005456 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL8386178 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL10715048 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL9005462 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL5888741 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL4377664 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL8091382 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL5888744 | 1.00 | GRIK1 (1.00) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2345526-B1 | MOLD FOR NANOIMPRINT | TOKYO INST TECH (JP) | 2014-02-12 | — | — | EP | disclosed |
| US-8222359-B2 | Poly(propargyl-L-glutamate) and derivatives thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-07-17 | — | — | US | disclosed |
| US-20110233820-A1 | MOLD FOR NANOIMPRINT | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2011-09-29 | — | — | US | disclosed |
| CN-102164733-A | Mold for nanoimprint | TOKYO INST TECH | 2011-08-24 | — | — | CN | disclosed |
| EP-2345526-A1 | MOLD FOR NANOIMPRINT | Tokyo Institute of Technology (JP) | 2011-07-20 | — | — | EP | disclosed |
| US-20110097419-A1 | Poly(Propargyl-L-Glutamate) and Derivatives Thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-04-28 | — | — | US | disclosed |
| EP-0338702-B1 | Nonlinear optical materials | NIPPON OIL CO LTD (JP) | 1994-06-29 | — | — | EP | disclosed |
| US-5097016-A | Blending a polypeptide or polylactam and a nitro-containing urea, enone, aniline, heterocyclic, stilbene or merocyanine derivative; no secondary harmonic generation; easy phase matching | NIPPON OIL CO., LTD. (JP) | 1992-03-17 | — | — | US | disclosed |
| EP-0338702-A1 | Nonlinear optical materials | NIPPON OIL CO. LTD. (JP) | 1989-10-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110097419-A1 | Poly(Propargyl-L-Glutamate) and Derivatives Thereof | GLUL, QPCTL, QPCT | GRIK1 36/4885GRIK2 47/4885SLC1A2 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.